Your browser doesn't support javascript.
loading
Physalis angulata L. antineoplasic activity, in vitro, evaluation fromit's stems and fruit capsules
Ribeiro, I. M; Silva, M. T. G; Soares, R. D. A; Stutz, C. M; Bozza, M; Tomassini, T. C. B.
Affiliation
  • Ribeiro, I. M; Fiocruz. Far-Manguinhos. Laboratório de Química Produtos Naturais, PN2. Rio de Janeiro. BR
  • Silva, M. T. G; Fiocruz. Far-Manguinhos. Laboratório de Química Produtos Naturais, PN2. Rio de Janeiro. BR
  • Soares, R. D. A; Fiocruz. IOC. DBBM. Laboratório de Imunopatologia. Rio de Janeiro. BR
  • Stutz, C. M; Fiocruz. Far-Manguinhos. Laboratório de Farmacologia Aplicada I. Rio de Janeiro. BR
  • Bozza, M; CCS. Laboratório de Informação e Imunidade. Rio de Janeiro. BR
  • Tomassini, T. C. B; Fiocruz. Far-Manguinhos. Laboratório de Química Produtos Naturais, PN2. Rio de Janeiro. BR
Rev. bras. farmacogn ; 12(supl.1): 21-23, 2002. tab
Article in En | LILACS | ID: lil-528734
Responsible library: BR1.1
ABSTRACT
Physalis angulata L. (genus Physalis; family Solanaceae) is an herbaceous specimen that grows plentifully at North, Northeast and Middleast Brazilian's regions1. Its fruits are edible, roots and epigeal parts are taken as tea or infusion, all through the world as traditional medicine. Despite of this usefulness not much scientific work has been done on it. This research carried out with plant material (stems and fruit capsules) has the main aim to find out anti-neoplasic activity. The obtained results are described in Table 1. The most significant inhibition values are those for fruit capsules fractions such as 97 percent mouse lymphoma; 93 percent Erlich carcinoma strains when was assayed with MGTS-1-2ai and MGTS-1-1ai respectively. In the course on going studies on the biological response and chemical constituents of P. angulata some fractions were obtained from stems and fruit capsules ethanolic and methanolic extracts. The extract prepared from roots of P. angulata is the most clinically used by physicians for treatment of human hepatic disorders, despite the substance responsible for the efficacy still a matter of argument.
Full text: 1 Index: LILACS Language: En Journal: Rev. bras. farmacogn Journal subject: FARMACIA Year: 2002 Type: Article
Full text: 1 Index: LILACS Language: En Journal: Rev. bras. farmacogn Journal subject: FARMACIA Year: 2002 Type: Article